Related Experiment Video
Updated: Nov 10, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.9K
Genetic Cardiomyopathies: The Lesson Learned from hiPSCs
Ilaria My1,2, Elisa Di Pasquale2,3
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
Journal of Clinical Medicine
|April 3, 2021
Summary
Genetic cardiomyopathies are inherited heart conditions causing significant health issues. Human stem cells and genomic technologies aid in understanding disease mechanisms and developing new therapies for conditions like hypertrophic cardiomyopathy.
Area of Science:
- Cardiovascular Research
- Genetics
- Stem Cell Biology
Background:
- Genetic cardiomyopathies are a major cause of illness and death in young individuals.
- These inherited heart diseases can lead to heart failure, arrhythmias, and sudden cardiac death.
- Understanding the pathogenicity of genetic variants is crucial for diagnosis and treatment.
Purpose of the Study:
- To review key research elucidating the pathophysiology of common genetic cardiomyopathies.
- To highlight the role of human induced pluripotent stem cells in creating patient-specific disease models.
- To focus on the application of gene-editing techniques and therapeutic strategies.
Main Methods:
- Review of scientific literature on genetic cardiomyopathies.
- Utilizing human induced pluripotent stem cells for in vitro modeling.
- Analysis of genomic technologies, including isogenic pairs.
- Examination of gene-editing techniques and therapeutic approaches.
Main Results:
- Human induced pluripotent stem cells provide valuable patient-specific models for studying disease mechanisms.
- Genomic technologies, particularly isogenic pairs, have advanced the exploration of cardiomyopathy genetics.
- Gene editing offers insights into disease characteristics and potential therapeutic targets.
Conclusions:
- Advances in stem cell and genomic technologies are crucial for understanding genetic cardiomyopathies.
- These tools enable detailed characterization of variants and the testing of novel therapeutic strategies.
- This review consolidates current knowledge on hypertrophic, dilated, arrhythmogenic cardiomyopathies, and left ventricular noncompaction.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
124
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
124
01:29Cardiomyopathy V: Interprofessional Care
106
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
106
01:30Cardiomyopathy II: Dilated Cardiomyopathy
129
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
129
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
172
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
172
01:25Cardiomyopathy I: Introduction and Classification
190
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
190